BRCA1 Germ‐Line Mutations and Tumor Characteristics in Eastern Chinese Women with Familial Breast Cancer |
| |
Authors: | Wenming Cao Xiaojia Wang Yun Gao Hongjian Yang Ji‐Cheng Li |
| |
Institution: | 1. Institute of Cell Biology, Zhejiang University, Hangzhou 310058, China;2. Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou 310022, China;3. Institute of Cancer Research, Zhejiang Cancer Hospital, Hangzhou 310022, China;4. Department of Breast Cancer Surgery, Zhejiang Cancer Hospital, Hangzhou 310022, China;5. Institute of Cell Biology, Zhejiang University, Hangzhou 310058, ChinaFax: 86‐571‐88208088 |
| |
Abstract: | Although several studies detected the BRCA1 germ‐line mutations in Chinese women with familial breast cancer, most of them did not employ conventional full gene sequencing, especially in eastern China. In addition, the clinicopathological features of BRCA1‐associated breast cancer in Chinese women were not well investigated. In this study, we screened the complete coding regions and exon‐intron boundaries of BRCA1 by polymerase chain reaction (PCR)‐sequencing assay. Immunohistochemistry analyses were performed on tumor samples to detect the expression of estrogen receptor (ER), progesterone receptor (PR), P53, and human epidermal growth factor receptor‐2 (HER‐2). Breast cancer patients having one or more affected relatives referred from the Zhejiang Cancer Hospital, eastern China during 2008–2011 were selected for the study. A total of 62 familial breast cancer patients received the BRCA1 germ‐line mutation screening. Five deleterious mutations were detected in this cohort. The mutation rate was 11.3% (7/62). We found two novel mutations (3414delC and 5,280 C > T) and two recurrent mutations (5,273 G > A and 5589del8). BRCA1 mutation tumors tended to be negative for ER, PR, and HER‐2, and exhibited high histological grade compared with tumors without BRCA1 mutations. Our study suggests that recurrent mutations may exist in eastern Chinese women with familial breast cancer and PCR‐sequencing assay is a useful tool to screen these mutations. It also suggests that BRCA1‐associated breast cancers in Chinese women exhibit an aggressive phenotype. Anat Rec, 2013. © 2012 Wiley Periodicals, Inc. |
| |
Keywords: | BRCA1 mutation Chinese women familial breast cancer clinical features |
|
|